| Authors: |
Banerjee R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Richards A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Midha S; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Afrough A; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Anwer F; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Atanackovic D; Division of Hematology/Oncology, University of Maryland, Baltimore, MD., Atrash S; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Bachanova V; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN., Beitinjaneh AM; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL., Bhurtel E; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS., Castaneda Puglianini O; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Chhabra S; Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ., Cicero KI; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Davis JA; Department of Pharmacy, Medical University of South Carolina, Charleston, SC., Dhakal B; Division of Hematology, Medical College of Wisconsin, Milwaukee, WI., Dima D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Ferreri CJ; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Forsberg PA; Division of Hematology/Oncology, Colorado Blood Cancer Institute, Denver, CO., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Herr MM; Division of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Jain T; Division of Hematology/Oncology, Johns Hopkins University, Baltimore, MD., Janakiram M; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA., Khouri J; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Kocoglu MH; Division of Hematology/Oncology, University of Maryland, Baltimore, MD., Kumar A; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA., Liu Y; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Locke F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS., Mikkilineni L; Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA., Nadeem O; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Parrondo RD; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL., Pasvolsky O; Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX., Peres LC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Purvey S; Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA., Raza S; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH., Reshef R; Division of Hematology/Oncology, Columbia Irving Medical Center, New York City, NY., Richard S; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY., Rossi AC; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY., Sborov DW; Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS., Wagner CB; Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Zanwar SS; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN., Sidana S; Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA., Patel KK; Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX., Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Kumar SK; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN., Lin Y; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN., Martin TG; Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA., Voorhees PM; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Anderson LD Jr; Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Kaur G; Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY. |
